A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy

In this study, the maximum tolerated dose (MTD) of lobaplatin (LBP) when it was combined with docetaxel (TXT) for the treatment of solid tumours that had progressed following chemotherapy was determined, and toxicities to this regimen were evaluated. A modified Fibonacci method was used for the dose...

Descripción completa

Detalles Bibliográficos
Autores principales: PENG, YU, LIU, YUE-E, REN, XIAO-CAN, CHEN, XUE-JI, SU, HUI-LING, ZONG, JIE, FENG, ZENG-LI, WANG, DONG-YING, LIN, QIANG, GAO, XIAN-SHU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246893/
https://www.ncbi.nlm.nih.gov/pubmed/25435935
http://dx.doi.org/10.3892/ol.2014.2675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246893/
https://www.ncbi.nlm.nih.gov/pubmed/25435935
http://dx.doi.org/10.3892/ol.2014.2675

Ejemplares similares